CalciMedica, Inc. Common Stock (CALC) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.92 (-2.54%), Market cap $0.01B, 52-week low–high $0.51 ~ $6.74.
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in
Financial statements, price targets, institutional (13F) holdings and related news for CalciMedica, Inc. Common Stock are updated in real time on BlackAll Trade.
CalciMedica, Inc. Common Stock trades at $1.92 (-2.54%). Real-time quotes and charts are available on BlackAll Trade.
CalciMedica, Inc. Common Stock has a market cap of about $0.01B.
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candida